BTLA Antikörper (AA 101-150)
Kurzübersicht für BTLA Antikörper (AA 101-150) (ABIN8119932)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-150
-
Verwendungszweck
- CD272 Antibody
-
Spezifität
- CD272 Polyclonal Antibody detects endogenous levels of CD272 protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthetic peptide from human protein at AA range: 101-150
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500 - 1:2000. IHC 1:200 - 1:1000. Flow cytometry: 1:200 - 1:400. ELISA: 1:10000.. IF 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C/1 year
-
Haltbarkeit
- 12 months
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- CD272
-
Hintergrund
-
Synonyms: BTLA, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein, CD antigen CD272
Background: This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis. [provided by RefSeq, Aug 2011],
Gene Name: BTLA
Protein Name: B- and T-lymphocyte attenuator
-
Gen-ID
- 151888
-
UniProt
- Q7Z6A9
-
Pathways
- Cancer Immune Checkpoints
Target
-